Protagonist Therapeutics, Inc.PTGXNASDAQ
LOADING
|||
Enterprise value to sales ratio
| Period | Value | Change |
|---|---|---|
| 2024 | 5.27 | -71.7% |
| 2023 | 18.60 | +19.7% |
| 2022 | 15.54 | -71.0% |
| 2021 | 53.60 | +163.7% |
| 2020 | 20.33 | -97.2% |
| 2019 | 721.03 | +32556.4% |
| 2018 | 2.21 | -83.1% |
| 2017 | 13.06 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |